Is the 21-Gene Recurrence Score on Core Needle Biopsy Equivalent to Surgical Specimen in Early-Stage Breast Cancer? A Comparison of Gene Expression Between Paired Core Needle Biopsy and Surgical Specimens - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34244898/
doi: 10.1245/s10434-021-10457-5. Online ahead of print. 1 Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA. 2 Center for Cardiovascular Analytics, Research and Data Science (CARDS),...
Clinical characteristics and disease outcomes in ER+ breast cancer: a comparison between HER2+ patients treated with trastuzumab and HER2- patients - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34256710/
doi: 10.1186/s12885-021-08555-4. 1 General Surgery Department, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 22nd Floor, 197 Ruijin Er Road, Shanghai, 200025, China. 2 General Surgery...
Role of the Combination of Cyclin-Dependent Kinase Inhibitors (CDKI) and Radiotherapy (RT) in the Treatment of Metastatic Breast Cancer (MBC): Advantages and Risks in Clinical Practice - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34221963/
Targeting cell cycle has become the gold standard for metastatic breast cancer (MBC), being cyclin-dependent kinase inhibitors (CDKIs) cornerstones of its treatment, alongside radiotherapy (RT). To date, no definite evidence...
-
Naveed Saleh, MD, MS – Skipta Team5yrKey Points • In metastatic breast cancer, targeting the cell cycle has emerged as standard treatment. Cyclin-dependent kinase inhibitors (CDKIs), as well as radiotherapy (RT), are mainstays of treatment. In the Show More
Cost evaluation of an exercise oncology intervention: The exercise in all chemotherapy trial - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34236137/
Our findings suggest that an exercise oncology program during active chemotherapy treatment are at least cost neutral for all cancer patients, including advanced stage cancers. Additional research is warranted to...
Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer: A SEER-based study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34232220/
The incidence of primary metastatic breast cancer (PMBC) has not decreased despite the increasing popularity of mammography screening and data on the survival among these patients are limited. Therefore, we...